A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis
Read time: 1 mins
Last updated:13th Jan 2014
This study will evaluate the safety and efficacy of pimavanserin 40 mg compared to placebo in patients with Alzheimer's disease psychosis.
|Study start date||2014-01-13|